Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 2 1

Status

Terminated 8Recruiting 7Active not recruiting 5Completed 4Unknown 2Withdrawn 1

Sponsor Class

OTHER 71INDUSTRY 7

Study Type

Observational 5Interventional 2

Sponsor

Cancer Type

Breast 3Lymphoid 2Tumor-Agnostic 1Thoracic 1Other hematologic neoplasm 1

Conditions

Carcinoma, Non-Small-Cell Lung 429Breast Neoplasms 298Neoplasms 296Colorectal Neoplasms 242Neoplasm Metastasis 197Ovarian Neoplasms 171Lung Neoplasms 150Recurrence 147Prostatic Neoplasms 146Pancreatic Neoplasms 142Multiple Myeloma 136Stomach Neoplasms 129Squamous Cell Carcinoma of Head and Neck 128Melanoma 123Leukemia, Myeloid, Acute 115Endometrial Neoplasms 115Advanced Solid Tumors 113Advanced Solid Tumor 108Carcinoma, Hepatocellular 102Triple Negative Breast Neoplasms 101Small Cell Lung Carcinoma 88Uterine Cervical Neoplasms 86Lymphoma, Non-Hodgkin 83Carcinoma, Renal Cell 72Lymphoma, Follicular 71Lymphoma 67Leukemia, Lymphocytic, Chronic, B-Cell 65Solid Tumor 64Lymphoma, Large B-Cell, Diffuse 64Hematologic Neoplasms 62

Interventions

fludarabine phosphate 1fludarabine 1Cyclophosphamide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

7 trials
RecentStart dateEnrollment
Recruiting × INDUSTRY × Neoplasm, Residual × Clear all
NCT05232916 2026-06-04

FLAMINGO-01

Greenwich LifeSciences, Inc.

Phase 3 Recruiting
750 enrolled
Breast

Breast Neoplasms, Neoplasm, Residual

NCT06500273 2026-06-02

ALPHA3

Allogene Therapeutics

Phase 2 Recruiting
250 enrolled
Lymphoid

Lymphoma, Large B-Cell, Diffuse, Neoplasm, Residual

NCT07211178 2026-03-04

GEMINI Breast

Tempus AI

Recruiting
900 enrolled
Breast

Breast Neoplasms, Neoplasm, Residual, Triple Negative Breast Neoplasms

NCT01499394 2026-01-21

Caris Biorepository Research Protocol

Caris Science, Inc.

Recruiting
100,000 enrolled
Tumor-Agnostic

Neoplasms, Neoplasm, Residual

NCT06963307 2025-05-09

LumenDx

JaxBio Ltd

Recruiting
300 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Neoplasm, Residual

NCT06230185 2025-01-07

B-STRONGER-I

Personalis Inc.

Recruiting
422 enrolled
Breast

Breast Neoplasms, Neoplasm, Residual, Triple Negative Breast Neoplasms

NCT04466059 2024-12-17

BELUGA

Munich Leukemia Laboratory

Recruiting
25,000 enrolled
LymphoidOther hematologic neoplasm

Leukemia, Lymphoma, Neoplasm, Residual, Hematologic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡